Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Non-Hodgkin

Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.

228 public trials 23 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Non-Hodgkin trial results

Completed

BI 836826 Dose Escalation in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma (NHL)

NCT01403948

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations
  • INS Paoli-Calmettes Marseille, France
  • HOP Lyon Sud Pierre-Bénite, France
  • Charité - Universitätsmedizin Berlin Berlin, Germany
  • Universitätsklinikum Carl Gustav Carus Dresden Dresden, Germany
View Trial Details
Completed

A Study Evaluating the Safety, Efficacy and Pharmacokinetics of Venetoclax Combined With Chemotherapy in Participants With B-Cell Non-Hodgkin's Lymphoma (NHL) and DLBCL

NCT02055820

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations
  • St. Jude Heritage Healthcare Fullerton, California, United States
  • UCLA Jonsson Comprehensive Cancer Center Los Angeles, California, United States
  • Central Coast Medical Oncology Santa Maria, California, United States
  • The West Clinici St Louis, Missouri, United States
View all 52 locations
View Trial Details
Completed

Epidemiology of Burkitt Lymphoma in East Africa Children or Minors (EMBLEM)

NCT01196520

Conditions
Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +20 more
Locations
  • Bugando Medical Center Mwanza, Tanzania
  • Shirati Health, Educational, and Development Foundation Shirati, Tanzania
  • St.Mary's Hospital Lacor Gulu, Uganda
  • Kuluva Hospital (Arua) Kampala, Uganda
View Trial Details
Completed

Phase 1 Nilotinib in Steroid Dependent/Refractory Chronic Graft Versus Host Disease

NCT01155817

Conditions
Bone Marrow Transplant Failure, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Stanford University School of Medicine Stanford, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
  • Fred Hutchinson Cancer Research Center Seattle, Washington, United States
View Trial Details
Completed

A Study Of PF-05082566 As A Single Agent And In Combination With Rituximab

NCT01307267

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +45 more
Locations
  • City of Hope Duarte, California, United States
  • UC San Diego Moores Cancer Center-Investigational Drug Services La Jolla, California, United States
  • UC San Diego Medical Center-La Jolla (Jacobs Medical Center/Thornton Hospital) La Jolla, California, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
View all 42 locations
View Trial Details
Completed

BBR 2778 for Relapsed, Aggressive Non-Hodgkin's Lymphoma (NHL)

NCT00088530

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations
  • Robert A. Moss, M.D., FACP, Inc. Fountain Valley, California, United States
  • UCLA Medical Center Los Angeles, California, United States
  • Watson Clinic for Cancer Care and Research Lakeland, Florida, United States
  • Rush University Medical Center Chicago, Illinois, United States
View all 99 locations
View Trial Details

Related conditions